The largest review of antioxidants for female subfertility, a 2020 Cochrane systematic review covering 63 trials and 7,760 women, rated the evidence for any live-birth benefit as very low certainty (and a 2026 editorial note records that several of its included trials have since been retracted or placed under expression of concern, which does not change its cautious conclusion and, if anything, reinforces it)
Semaglutide is not recommended for candidates who are pregnant, breastfeeding, are already taking a different GLP-1 medication, or have certain diseases or allergic reactionswe will let you know the specifics of these parameters when we meet with you to discuss your treatment
doi: 10.1016/j.neuint.2012.04.008
I told people I needed a change
From postnatal day 29 onwards, mice were administered a mash made of feed powder and water with or without 2 g ALCAR per kg feed